The tumor antigen WT1 located in the nucleus is overexpressed in both BP-CML and a variety of solid tumor cells, which was associated with drug resistance and poor prognosis. This evidence concerns the gene LINC01194 and chronic myelogenous leukemia, BCR-ABL1 positive.